1-8 of 8
Pawel J. Robak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Oral Ixazomib (Ixa), Intravenous (IV) Daratumumab (Dara), and IV/Oral Dexamethasone (Dex; IDd) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) and 1-3 Prior Therapies: Results of the Final Analysis of a Phase 2 Study

Sosana Delimpasi, Meletios A. Dimopoulos, Jan Straub, Argiris Symeonidis, Roman Hájek, Cyrille Touzeau, Viralkumar K. Bhanderi, Jesus Berdeja, Petr Pavlíček, Jeffrey V. Matous, Pawel J. Robak, Kaveri Suryanarayan, Miguel Villareal, Dasha Cherepanov, Jaydeep K. Srimani, Huilan Yao, Richard Labotka, Robert Z. Orlowski
Journal: Blood
Blood (2022) 140 (Supplement 1): 9995–9997.
https://doi.org/10.1182/blood-2022-163092
Published: 2022
Journal Articles

OCEAN (OP-103): Melflufen/Dexamethasone (Dex) Compared with Pomalidomide (Pom)/Dex in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) - Subgroup Analysis By Prior Alkylator Exposed/Refractory Status

Pieter Sonneveld, Maria-Victoria Mateos, Pawel J. Robak, Fredrik H. Schjesvold, Roman Hajek, Paul G. Richardson, Johan Harmenberg, Marcus Thuresson, Catriona Byrne, Meletios-Athanasios Dimopoulos
Journal: Blood
Blood (2021) 138 (Supplement 1): 4779.
https://doi.org/10.1182/blood-2021-146844
Published: 2021
Journal Articles

OCEAN (OP-103): Melflufen Plus Dexamethasone (Dex) Versus Pomalidomide (Pom) and Dex in Relapsed/Refractory Multiple Myeloma (RRMM) - Impact of Prior Treatments Analysis

Meletios-Athanasios Dimopoulos, Fredrik H. Schjesvold, María-Victoria Mateos, Pawel J. Robak, Roman Hájek, Paul G. Richardson, Jakob Lindberg, Marcus Thuresson, Kajsa Larsson, Pieter Sonneveld
Journal: Blood
Blood (2021) 138 (Supplement 1): 4780.
https://doi.org/10.1182/blood-2021-146994
Published: 2021
Journal Articles

OCEAN (OP-103): Melflufen/Dexamethasone Compared with Pomalidomide/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma-Age Subgroup Analysis of Older Patients

Maria-Victoria Mateos, Pawel J. Robak, Laura Rosiñol, Argiris Symeonidis, Pieter Sonneveld, Marcus Thuresson, Catriona Byrne, Johan Harmenberg, Roman Hájek
Journal: Blood
Blood (2021) 138 (Supplement 1): 2741.
https://doi.org/10.1182/blood-2021-147005
Published: 2021
Journal Articles

Early Mortality in Patients with Multiple Myeloma Treated with Novel Agents - Analysis from Polish Myeloma Study Group

Grzegorz Charlinski, MDPhD, Agata Tyczyńska, MD, Jan M Zaucha, MD PhD, Adriana Czyz, MD, Jarosław Czyż, MDPhD, Dominik Dytfeld, MDPhD, Bartosz Malecki, MD, Lidia Gil, MDPhD, Szymon Fornagiel, MD, Sebastian Grosicki, MD PhD, Agnieszka Barchnicka, MD, Jadwiga Holojda, MD, Agnieszka Kolkowska, MD PhD, Iwona Hus, MD PhD, Grzegorz Helbig, MDPhD, Anna Kopinska, MD, Anna Masternak, MD, Dariusz Woszczyk, MDPhD, Miroslaw Markiewicz, MDPhD, Jaroslaw Piszcz, MDPhD, Janusz Kloczko, MDPhD, Lidia Usnarska-Zubkiewicz, MDPhD, Tomasz Wrobel, MD PhD, Pawel J. Robak, MDPhD, Tadeusz Robak, MDPhD, Anna Waszczuk-Gajda, MD, Grzegorz Basak, MD PhD, Artur Jurczyszyn, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-143003
Published: 2020
Journal Articles

Safety and Preliminary Efficacy Results from a Phase Ib/II Study of Cobimetinib As a Single Agent and in Combination with Venetoclax with or without Atezolizumab in Patients with Relapsed/Refractory Multiple Myeloma

Fredrik Schjesvold, Vincent Ribrag, MD, Paula Rodriguez-Otero, MD PhD, Pawel J. Robak, MDPhD, Markus Hansson, MD, Roman Hajek, Adrián Alegre Amor, MD PhD, Joaquin Martinez-López, Maika Onishi, Jorge D. Gallo, Aparna Raval, Sameer Deshpande, Vikram Malhi, Wan-Jen Hong, MD, Marc S. Raab, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-135845
Published: 2020
Journal Articles

Preemptive Daratumumab Therapy for Minimal Residual Disease Reappearance or Biochemical Relapse in Multiple Myeloma: Rationale and Design of the Polish Myeloma Consortium Predator Study

Krzysztof Jamroziak, Krzysztof Giannopoulos, Tomasz Wrobel, MD PhD, Adam Nowicki, Bartosz Pula, Norbert Grząśko, Justyna Rybka, Paweł J. Robak, MD, Agnieszka Druzd-Sitek, Adam Walter-Croneck, Katarzyna Brzeźniakiewicz-Janus, MDPhD, Jarosław Czyż, Krzysztof Warzocha, Dominik Dytfeld
Journal: Blood
Blood (2017) 130 (Supplement 1): 5404.
https://doi.org/10.1182/blood.V130.Suppl_1.5404.5404
Published: 2017
Journal Articles

Subcutaneous Compared to Intravenous Administration of Rituximab Plus CHOP in Patients with Diffuse Large B-Cell Lymphoma — a Study By the Polish Lymphoma Research Group

Ewa Paszkiewicz-Kozik, Monika Dlugosz-Danecka, MD PhD, Paweł J. Robak, MD, Elżbieta Wojciechowska-Lampka, MD, Monika Swierkowska-Czeneszew, MD, Joanna Tajer, MD PhD, Joanna Romejko-Jarosinska, MD PhD, Katarzyna Domanska-Czyz, MD, Marcin Szymanski, MD, Marta Morawska, MD, Lukasz Targonski, MD, Michal Osowiecki, MD, Beata Ostrowska, MDPhD, Anna Paulina Dabrowska-Iwanicka, MD PhD, Jan Walewski, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5217.
https://doi.org/10.1182/blood.V130.Suppl_1.5217.5217
Published: 2017